a 1 -adrenoceptors are widely distributed in the human body and play important physiologic roles. Three a 1 -adrenoceptor subtypes (a 1A , a 1B and a 1D ) have been cloned and show diŠerent pharmacologic proˆles. In addition, a putative a 1 -adrenoceptor (a 1L subtype) has also been proposed. Recently, three drugs (tamsulosin, naftopidil, and silodosin) have been developed in Japan for the treatment of urinary obstruction in patients with benign prostatic hyperplasia. In this review, we describe recent a 1 -adrenoceptor subclassiˆcations and the pharmacologic characteristics (subtype selectivity and clinical relevance) of a 1 -adrenoceptor antagonists.
代表的薬物の a 1 サブタイプ選択性を Table 2 に 
Fig. 6. EŠects of Prazosin and Silodosin on Concentration-response Curves for Noradrenaline in Human Mesenteric Artery (A) and Prostate (B)
After recording the control responses, prazosin (3×10 -9 M) and silodosin (10 -9 M) were treated and then the responses to noradrenaline were examined. 
